Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody 2020-08-17 08:30
Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad 2020-08-17 08:00
China's First Trastuzumab Biosimilar Approved by NMPA 2020-08-17 08:00
Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index 2020-08-17 07:30
Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19 2020-08-15 08:36
Family Mask Supports UNGC Leaders' Summit 2020 2020-08-14 15:30
Sinopharm Tech plans to purchase 337 tons Meltblown Fabric 2020-08-14 09:18
Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters for Contempt on Patent and Trademark Infringement Case 2020-08-14 02:32
Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Updates 2020-08-13 22:38
AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage 2020-08-13 21:00
ANTI-PD-1/CTLA-4 Bi-specific Antibody (AK104) of Akeso Granted FDA Fast Track Designation for Recurrent and Metastatic Cervical Cancer 2020-08-13 20:07
Ajinomoto Bio-Pharma Services Expands Small Molecule Manufacturing Capabilities at its India Facility 2020-08-13 20:06
CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company 2020-08-13 10:00
Australian Therapeutic Goods Administration Approves the First Phase I Trial of ATG-017 for the Treatment of Patients with Advanced Solid Tumors and Hematological Malignancies 2020-08-13 06:00
Health Canada provides COVID-19 Interim Order approval for Bactiguard's endotracheal tubes 2020-08-13 04:33
Innovent and Eli Lilly Announce Acceptance of a Supplemental New Drug Application of TYVYT® (Sintilimab Injection) in Combination with Gemcitabine and Platinum as First-Line Therapy in Squamous Non-Small Cell Lung Cancer in China 2020-08-12 16:40
PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season 2020-08-11 18:35
TCM Lianhua Qingwen Capsule approved for registration in the Philippines 2020-08-11 17:31
OssDsign AB signs business partner agreement with Muranaka Medical Instruments Co., Ltd., in Japan 2020-08-11 15:50
Trendlines Medical Shanghai Opens its Doors 2020-08-11 07:01
1 349 350 351 352 353 531